Reading Time: < 1 minute The U.S. Food and Drug Administration on Thursday approved GlaxoSmithKline Plc’s HIV drug, Rukobia, to treat adult patients, Read More

Reading Time: < 1 minute A study published in the journal Nature on July 1 suggests that there may be a new way to target an HIV…

Reading Time: < 1 minute   Adolescents in Uganda living with HIV risk becoming critically ill or dying because they fear to disclose their status. Read More

Reading Time: < 1 minute GlaxoSmithKline’s HIV business ViiV is within weeks of resubmitting its request for approval of its long-acting injection Cabenuva Read More

Reading Time: < 1 minute   It has been a steep learning curve since I joined UNAIDS. Read More

Reading Time: < 1 minute  The organizers of HIV2020 Online published a set of ten recommendations aimed at the International AIDS Society (IAS), which has been criticized…

Reading Time: < 1 minute   I was in a long-term relationship for two years with someone I loved, we had recently bought a puppy together, Read more